ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Small-Cell Lung Cancer in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Lung Cancer
Colorectal Cancer
Cancer
Squamous Cell Carcinoma of Head and Neck
Neoplasm Metastasis
Melanoma

Non-Small-Cell Lung Cancer trials near San Francisco, CA, USA:

Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery

with stage I-IIIA Epithelial Growth Factor Receptor (EGFR) -mutant non-small cell lung cancer before sur ...

Active, not recruiting
Stage IA Non-Small Cell Lung Cancer
Stage IIIA Non-Small Cell Lung Cancer
Procedure: Therapeutic Conventional Surgery
Drug: Osimertinib

Phase 2

University of California San Francisco (UCSF)
University of California San Francisco (UCSF)

San Francisco, California, United States and 2 other locations

This is a Phase II, multi-center, open-label platform study evaluating novel combination treatment options in participants with locally advanced or m...

Enrolling
Non-Small Cell Lung Cancer
Drug: Dato-DXd
Drug: Ramucirumab

Phase 2

AstraZeneca
AstraZeneca

Santa Rosa, California, United States and 82 other locations

purpose of this study is to evaluate how well Rina-S works against lung cancer.The treatment in this study is Rina-S monotherapy (b...

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Drug: Rina-S

Phase 2

Genmab
Genmab

Santa Rosa, California, United States and 73 other locations

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. The first t ...

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Drug: Setidegrasib
Drug: Docetaxel

Phase 3

Astellas
Astellas

San Francisco, California, United States and 16 other locations

The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...

Enrolling
Non-small Cell Lung Cancer
Drug: Nab-paclitaxel
Drug: Pembrolizumab

Phase 3

AstraZeneca
AstraZeneca

San Francisco, California, United States and 327 other locations

alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Pemetrexed/Carboplatin
Drug: Pemetrexed/Cisplatin

Phase 3

AstraZeneca
AstraZeneca

Santa Rosa, California, United States and 152 other locations

This is a pilot study using \[18F\]F AraG PET imaging to evaluate the immunological response to checkpoint inhibitor therapy (CkIT) in patients with...

Enrolling
Non Small Cell Lung Cancer
Drug: [18F]F AraG

Phase 2

CellSight Technologies

Palo Alto, California, United States and 2 other locations

in combination with pembrolizumab in participants with advanced non-small cell lung cancer (NSCLC) or ho....

Active, not recruiting
Breast Cancer
Non Small Cell Lung Cancer
Drug: Abemaciclib
Drug: Anastrozole

Phase 1

Lilly
Lilly

San Francisco, California, United States and 23 other locations

in subjects with locally advanced and unresectable or metastatic non-small cell lung cancer with a KRAS ...

Enrolling
Metastatic Non-Small Cell Lung Cancer
Advanced Lung Carcinoma
Drug: Pembrolizumab
Drug: BBO-10203

Phase 1

TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

San Francisco, California, United States and 37 other locations

resectable, early-stage non-small cell lung cancer....

Enrolling
Non-small Cell Lung Cancer
Drug: Cisplatin
Drug: Rilvegostomig

Phase 2

AstraZeneca
AstraZeneca

Oakland, California, United States and 95 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems